NPCE
NPCE
NASDAQ · Health Care

Neuropace Inc

$15.36
-0.43 (-2.72%)
Financial Highlights (FY 2026)
Revenue
107.09M
Net Income
-22,991,616
Gross Margin
77.2%
Profit Margin
-21.5%
Rev Growth
+30.0%
D/E Ratio
3.09
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 77.2% 77.2% 46.3% 46.3%
Operating Margin -16.8% -15.2% 8.2% 8.2%
Profit Margin -21.5% -20.4% 8.6% 7.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 107.09M 82.39M 354.79M 322.64M
Gross Profit 82.71M 63.63M 164.26M 149.37M
Operating Income -18,034,506 -12,486,387 29.06M 26.44M
Net Income -22,991,616 -15,918,497 30.47M 23.82M
Gross Margin 77.2% 77.2% 46.3% 46.3%
Operating Margin -16.8% -15.2% 8.2% 8.2%
Profit Margin -21.5% -20.4% 8.6% 7.4%
Rev Growth +30.0% +30.0% -3.6% +12.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 203.42M 203.42M 135.86M 137.71M
Total Equity 65.75M 65.75M 359.61M 343.18M
D/E Ratio 3.09 3.09 0.38 0.40
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -17,979,724 -13,140,039 37.66M 35.61M
Free Cash Flow 33.72M 30.25M